Why not to stop antiviral treatment in patients with chronic hepatitis B

E-ISSN： 1478-3231|38|S1|97-101

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.S1, 2018-02, pp. : 97-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clevudine Demonstrates Potent Antiviral Activity in Naïve Chronic Hepatitis B Patients

Intervirology, Vol. 53, Iss. 2, 2009-12 ,pp. : 83-86

Karger

Access to resources Recommend Favorite

Antiviral Therapy of Chronic Hepatitis B

Intervirology, Vol. 57, Iss. 3-4, 2014-07 ,pp. : 171-180

Karger

Access to resources Recommend Favorite

Antiviral treatment of chronic hepatitis C in clinical routine

By Maieron Andreas

Wiener klinische Wochenschrift, Vol. 122, Iss. 7-8, 2010-04 ,pp. : 237-242

Springer Publishing Company

Access to resources Recommend Favorite

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 730-737

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of antiviral therapy with Telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients

By Shi T.

Clinical and Experimental Medicine, Vol. 12, Iss. 2, 2012-06 ,pp. : 105-113

Springer Publishing Company

Access to resources Recommend Favorite